12.20.11
ENGAGE 501 Poster Presented by Dr. Anas Younes at ASH 2011
Read More
12.11.11
Entinostat Demonstrates Activity in Hodgkin's Lymphoma
Read More
12.07.11
Survival Benefit With Syndax Pharmaceuticals' Entinostat Maintained in Women with Advanced Breast Cancer
Read More
12.07.11
ENCORE 301 Poster Presented by Dr. Denise Yardley at SABCS
Read More
12.01.11
Multiple Data Presentations on Syndax Pharmaceutical's Entinostat at Upcoming Scientific Conferences
Read More
11.13.11
Syndax Pharmaceuticals Presents Data Linking Pharmacodynamic Marker to Clinical Benefit in Advanced Breast Cancer Patients
Read More
11.05.11
Bio-Technology Corporations, Banking Institutions and MGH Support the Breathe Deep Boston 5K Walk 2011 in this Difficult Economy
Read More
11.02.11
Pharmacodynamic Data from Syndax Pharmaceutical's ENCORE 301 Study in Advanced Breast Cancer to be Highlighted at the AACR Molecular Targets and Cancer Therapeutics Conference 2011
Read More
10.24.11
Syndax Pharmaceuticals to Present at Upcoming Fall Conferences
Read More
09.06.11
Syndax Pharmaceutical's Positive Phase 2 Data Supports Potential for Entinostat in Advanced Breast Cancer
Read More
08.31.11
Syndax Pharmaceuticals to Present at Upcoming Fall Financial Conferences
Read More
08.24.11
Results of Syndax Pharmaceutical's ENCORE 301 Study in Advanced Breast Cancer to be Highlighted at the ASCO Breast Cancer Symposium 2011
Results of Syndax Pharmaceutical's ENCORE 301 Study in Advanced Breast Cancer to be Highlighted at the ASCO Breast Cancer Symposium 2011 Oral presentation will take place Saturday, September 10, 2011
Read More